Literature DB >> 17895760

Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma.

Vikram Deshpande1, Gunnlaugur Petur Nielsen, Daniel I Rosenthal, Andrew E Rosenberg.   

Abstract

BACKGROUND: Previous studies have documented the existence of intraosseous benign notochordal cell tumors (BNCTs) within the axial skeleton. Evidence suggests that they may be associated with the development of chordomas. To further investigate the relationship between BNCT and classic chordoma, we reviewed a large series of resected sacral/coccygeal chordomas in an attempt to identify the presence of coexisting BNCTs.
DESIGN: Eighty-two sacrectomy/coccygectomy specimens performed for chordoma were identified. Available hematoxylin and eosin slides were reviewed to identify BNCTs and assess their relationship with the coexisting chordoma. BNCTs were defined, in accordance with prior descriptions, as cohesive aggregates of large cells that appeared adipocyte-like because of their vacuolated cytoplasm. The cells exhibited only minimal nuclear atypia and lacked lobulation and myxoid stroma.
RESULTS: We identified 6 BNCTs, each was adjacent to but separate from the sacral chordoma. There were 5 females and 1 male, and the mean age was 58 years. Five lesions arose in the sacrum. One lesion arose in the coccyx, and involved 2 contiguous vertebral levels. The BNCTs ranged in size from 1 to 20 mm with a mean size of 6.1 mm. The lesions were exclusively composed of adipocyte-like nuclei without significant nuclear atypia or myxoid stroma. Three lesions contained sclerotic bony trabeculae and intralesional hematopoietic elements were identified in 1 case. In all cases the chordoma was of the conventional type and were morphologically different from the BNCT.
CONCLUSIONS: BNCTs were identified in 7.3% of sacral/coccygeal resections performed for primary chordoma. We speculate that this finding provides further evidence that BNCT is the precursor lesion for chordoma. Additional investigations are needed to further understand this relationship.

Entities:  

Mesh:

Year:  2007        PMID: 17895760     DOI: 10.1097/PAS.0b013e31805c9967

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Chordoma arising from benign multifocal notochordal tumors.

Authors:  Abdulrehman Arain; Francis John Hornicek; Joseph H Schwab; Ivan Chebib; Timothy A Damron
Journal:  Skeletal Radiol       Date:  2017-08-03       Impact factor: 2.199

2.  On "clivus chordoma: is it enough to image the primary site?" (skull base 2010;20:111-113).

Authors:  Takehiko Yamaguchi
Journal:  Skull Base       Date:  2011-07

Review 3.  Benign notochordal lesions of the axial skeleton: a review and current appraisal.

Authors:  Michael Kyriakos
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

4.  Benign notochordal cell tumor: a retrospective study of 11 cases with 13 vertebra bodies.

Authors:  Xiaomei Ma; Chunyan Xia; Dong Liu; Huimin Liu; Chenguang Wang; Hongyu Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Lumbar vertebral chordoma arising from an intraosseous benign notochordal cell tumour: radiological findings and histopathological description with a good clinical outcome.

Authors:  T Nishiguchi; K Mochizuki; T Tsujio; T Nishita; Y Inoue
Journal:  Br J Radiol       Date:  2010-03       Impact factor: 3.039

6.  Expression and Therapeutic Potential of SOX9 in Chordoma.

Authors:  Hua Chen; Cassandra C Garbutt; Dimitrios Spentzos; Edwin Choy; Francis J Hornicek; Zhenfeng Duan
Journal:  Clin Cancer Res       Date:  2017-06-12       Impact factor: 12.531

Review 7.  The biological basis for modern treatment of chordoma.

Authors:  Roberto Jose Diaz; Michael D Cusimano
Journal:  J Neurooncol       Date:  2011-03-08       Impact factor: 4.130

8.  Diagnostic imaging dilemma of a clival lesion and its clinical management implications.

Authors:  Sung-Joo Yuh; John Woulfe; Martin J Corsten; Ricardo L Carrau; Daniel M Prevedello; Amin B Kassam
Journal:  J Neurol Surg B Skull Base       Date:  2014-03-03

9.  Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas.

Authors:  Rajni Yadav; Mehar Chand Sharma; Prit Benny Malgulwar; Pankaj Pathak; Elanthenral Sigamani; Vaishali Suri; Chitra Sarkar; Amandeep Kumar; Manmohan Singh; Bhawani Shankar Sharma; Ajay Garg; Sameer Bakhshi; Mohammed Faruq
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

10.  Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets.

Authors:  Salvatore Di Maio; Esther Kong; Stephen Yip; Robert Rostomily
Journal:  Surg Neurol Int       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.